2m 2m 2m 2m 2m 2m 2m
INOVIO PHARMA (INO)
NASDAQ
$1.21-$0.04 (-3.60%)
Price as of Sep 11, 2026 7:42 PM EDT- $129.2MMarket Cap
- -47.48%1-Year Change
- BiotechnologyIndustry
INOVIO PHARMA (INO)
$1.21-$0.04 (-3.60%)
INO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.25 | ||
Change | -$0.03 (-2.34%) | ||
Open | $1.30 | ||
High | $1.31 | ||
Low | $1.23 | ||
Previous Close | $1.28 | ||
Volume | 2,392,904 | ||
30-Day Average Volume | 4,626,731 | ||
1-Week Change | -12.59% | ||
1-Month Change | 63.23% | ||
1-Year Change | -47.48% | ||
3-Year Change | -77.26% | ||
5-Year Change | -98.69% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $49.4M | ||
Market Cap | $129.2M | ||
Enterprise Value | $97.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$6.0M | ||
EBITDA | -$5.7M | ||
Net Working Capital | -$1,810.00 | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 30 | ||
P/E | -18 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/25/2024 | ||
Earnings & Revenue